Trade names from 'ср-кларен' to 'стерицеф®' - Electronic medicinal reference book ГЭОТАР

Tablets of prolonged action, film-coated, 500 mg.

Solution for infusions 6%.
Capsules of 30 mg, 40 mg. Primary packaging of medicinal product. 10 capsules per circuit cell packaging from film
Capsules 30 mg, 40 mg.By 7, 8, 10, 14, 28 capsules in a contour mesh box made of a polyvinyl chloride film and aluminum foil foil
Capsules 30 and 40 mg. For 60 capsules in polyethylene bottles of white color, sealed with a screwed polypropylene lid, with
Capsules of 30 mg and 40 mg. In the production of Heterose Labs Limited, India 10 capsules in a blister of a polyvinylchloride film and foil
Solution for intravenous administration 50 mg / ml. 5 ml into neutral glass ampoules.
Tablets, film-coated 50 mg / 12.5 mg / 200 mg; _100 mg / 25 mg / 200 mg; 150 mg / 37.5 mg / 200 mg.
Drops are sublingual, 10 RI / ml and 300 IR / ml.
Drops sublingual 10 IR / ml, 300 IR / ml.

Tablets 5 mg or 10 mg.

Tablets coated with 60 mg, 120 mg, 180 mg 12 tablets in a blister. 1, 2, 5, 7, 10 or 30 blisters with instructions for use in
Novartis Pharma AG Switzerland

Tablets 1.75 mg, 3.5 mg and 5 mg.

A solution for subcutaneous administration is 90 mg / ml.

Solution for subcutaneous administration.

Ointment for external use 3%.
Drops for topical administration and oral administration 40 mg / ml.
Ointment for external use 3%.

Solution for injection 10 mg / ml.

Spray nasal dosed with 25 mcg / dose.
Solution for intramuscular injection 0.1 mg / ml.
Nasal drops of 0.1 mg / ml.
homeopathic granules
Powder for solution for injection at 250 mg, 500 mg and 1.0 g.